2851 - 2860 of 8808 Results
Title
Year
-
RESTRICTEDTitle: New Questions About a Mysterious Neurologic Cluster in CanadaJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 17Start Page: 1,20End Page: 21Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000792776.14362.2bCitation Count: 0
-
RESTRICTEDTitle: Novel Genes May Drive Progression in Parkinson's DiseaseJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 12Start Page: 25End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000756456.16968.c1Citation Count: 0
-
RESTRICTEDTitle: The Parkinson's Detective, Caroline M. Tanner, MD, PhD, FAAN, on Environmental Factors and PreventionJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 9Start Page: 8End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000752844.66769.73Citation Count: 0
-
RESTRICTEDTitle: How to Increase Diverse Representation in Parkinson's Disease TrialsJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page: 20End Page: 22Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805216.68841.48Citation Count: 0
-
RESTRICTEDTitle: For Some Neurologists, COVID-19 Has Prompted an ‘Existential Crisis’Journal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805196.94665.beCitation Count: 0
-
RESTRICTEDTitle: MS Study That Spans Decades Indicates Patients Benefit from Early Diagnosis and TreatmentJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page: 1,17End Page: 20Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805208.98399.94Citation Count: 0
-
RESTRICTEDTitle: New Insights from a Two-Country Study Comparing Escalation Strategies for MS DrugsJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 19Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000797988.61856.80Citation Count: 0
-
OPENTitle: Quality Improvement in NeurologyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 97Issue #: 5Start Page: 239End Page: 245Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000012198Best OA location URL: https://n.neurology.org/content/neurology/97/5/239.full.pdfCitation Count: 17
-
OPENTitle: Prescribing Aducanumab in the Face of Meager Efficacy and Real RisksJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 97Issue #: 11Start Page: 545End Page: 547Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000012452Best OA location URL: https://n.neurology.org/content/neurology/97/11/545.full.pdfCitation Count: 31
-
OPENTitle: Cerebral Amyloid Angiopathy Is Associated With Emotional Dysregulation, Impulse Dyscontrol, and ApathyJournal Name: Journal of the American Heart AssociationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 10Issue #: 22Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1161/jaha.121.022089Best OA location URL: https://www.ahajournals.org/doi/pdf/10.1161/JAHA.121.022089Citation Count: 18